Iconic Tech Executive to Chair 5BARzBoard of Directors
SEATTLE–(BUSINESSWIRE)–November 21, 2013
5BARz International Inc. (OTCBB:BARZ), a leader in the cellular network extender technology industry, announcedtoday that Dr. Gil Amelio has been elected Chair of the 5BARz Board ofDirectors, effective immediately.
An iconic technology executive andinvestor, Dr. Amelio recently stepped down from the AT&T Board of Directorsto assume a more hands-on role in executing 5BARz’s accelerated growthstrategy. Throughout a career span of over three decades, Dr. Amelio has ledvarious technology companies, including serving as the CEO and chairman ofApple Computer; the president, CEO and chairman of National Semiconductor; andthe president of Rockwell Communication Systems, a unit of RockwellInternational. Under his leadership, these companies underwent successfultransformations that resulted in over $9 billion USD increase in investorvalue.
“I am delighted to be a part ofthe 5BARz team and to help this exciting Company meet its marketpotential,” said Gil Amelio. “5BARz is uniquely positioned to servethe growing need to extend cellular coverage to areas with poor signal levels.The opportunity to cost effectively enhance existing infrastructure representsan enormous market opportunity that we intend to continue to develop,” headded.
Prior to his management career, Dr.Amelio was a successful technologist. He developed the first practical chargecoupled (CCD) image sensor, which has been used to register images in consumercamcorders, digital still cameras, TV cameras and the Hubble Space Telescope.He has also patented important technology developments in semiconductorelectronics and energy management.
“Gil is an iconic businessleader and visionary with an impressive track record in helping take companieswith great ideas and products to the next level. We are delighted to have anexecutive with his exceptional background and experience leading our Board ofDirectors,” said Daniel Bland, 5BARz’s CEO.
Dr. Amelio currently serves on theboards of InterDigital, Inc. and Galectin Therapeutics. A former director andchairman of the Semiconductor Industry Association, he served as advisor to theMalaysia Multimedia Super Corridor and to Malaysia’s Prime Minister from 1996to 2009. Dr. Amelio was a Director of Chiron (1991 to 1996) andPTG-SBC-AT&T, Inc. (1995 to 2013) and served as Lead Director from 2009through 2010. He also served on the boards of Sematech and the American FilmInstitute.
Dr. Amelio, who earned his Ph.D. inphysics at Georgia Tech, has authored three books and is the holder of 17patents. He served his alma mater on the Georgia Tech Advisory Board twice andas Chairman 1985-1986.
About 5BARz International Inc.
The 5BARz International Inc. businessis focused upon the global commercialization of a patented product technologybranded under the name 5BARz(TM). 5BARz(TM) is a cellular networkinfrastructure device for use in the small office, home or for when users aremobile. 5BARz(TM) incorporates a patented technology to create a highlyengineered, single-piece, plug ‘n play unit that strengthens weak cellularsignals to deliver high quality signals for voice, data and video reception oncell phones and other cellular equipped devices. 5BARz(TM) represents a keysolution for cellular network operators in providing clear, high quality signalfor their subscribers with a growing need for high quality connectivity. 5BARzInternational Inc.’s shares are publicly traded on the OTCBB under the tickersymbol BARZ in the US and on the Berlin Stock Exchange(http://www.boerse-berlin.com) under symbol “O5B.”
On behalf of the Board of Directors
“Mr. Daniel Bland” CEO& Director
5BARz International Inc.
Legal Notice RegardingForward-Looking Statements
The information contained in thisrelease consists of forward-looking statements within the meaning of Section27A of the Securities Act and Section 21E of the Exchange Act. These statementsmay involve risks and uncertainties that could cause actual results to differmaterially from those described in such statements. Such forward-lookingstatements involve known and unknown risks and uncertainties, including allbusiness uncertainties relating to product development, marketing, marketacceptance, future capital requirements, and competition in general that maycause actual results to be materially different from those described herein asanticipated, believed, estimated or expected. The Company is under noobligation to (and expressly disclaims any such obligation to) update or alterits forward-looking statements whether as a result of new information, futureevents or otherwise.
SOURCE:5BARz International Inc. CopyrightBusiness Wire 2013
Order free Annual Report for 5Barz International, Inc.
Visit http://djnweurope.ar.wilink.com/?ticker=US33833F1003 orcall +44 (0)208 391 6028
To view on the Wall Street Journal, please visit: http://online.wsj.com/article/PR-CO-20131121-906821.html?dsk=y#printMode